×
GreekEnglish

×
  • Politics
  • Diaspora
  • World
  • Lifestyle
  • Travel
  • Culture
  • Sports
  • Cooking
Friday
21
Aug 2026
weather symbol
Athens 31°C
  • Home
  • Politics
  • Economy
  • World
  • Diaspora
  • Lifestyle
  • Travel
  • Culture
  • Sports
  • Mediterranean Cooking
  • Weather
Contact follow Protothema:
Powered by Cloudevo
> World

Revolutionary cancer treatment: 9 out of 10 patients with leukaemia were cured

More than nine out of ten participants with a severe form of leukaemia saw their symptoms completely vanish

Newsroom February 16 11:22

Δείτε περισσότερα άρθρα μας στα αποτελέσματα αναζήτησης

Add Protothema.gr on Google

A revolutionary treatment of cancer that could stop the disease from ever coming back will soon become widely available, scientists said yesterday.

According to Sky News, US scientists developed a new cancer drug which offers hope of a lasting cure.

More than nine out of ten participants with a severe form of leukaemia saw their symptoms completely vanish.

Four out of five patients with some other blood cancers responded positively to the treatment and more than half ended up symptom free.

The technique involves the removal of immune cells called T-cells from patients and tagging them with “receptor” molecules that target cancer. Then, they are put back into the patient in an infusion.

The targeting molecules, known as chimeric antigen receptors or Cars, came from specially bred genetically engineered mice.

>Related articles

Former Abercrombie & Fitch chief executive ruled fit for trial despite Alzheimer’s claims

Passengers save bus carrying 50 people in Sweden after driver loses consciousness (video)

Israeli PM Netanyahu brands Turkish President Erdogan ‘antisemitic dictator’ after Interpol arrest warrant

Once attached to the T-cells, they reduce the ability of the cancer to shield itself from the body’s natural immune system.

Lead scientist Professor Stanley Riddell, from the Fred Hutchinson Cancer Research Center in Seattle, US, said the results were among patients who were projected to have two to five months to live.

“This is extraordinary. This is unprecedented in medicine to be honest, to get response rates in this range in these very advanced patients.” he said.

Ask me anything

Explore related questions

> More World

Follow en.protothema.gr on Google News and be the first to know all the news

See all the latest News from Greece and the World, the moment they happen, at en.protothema.gr

> Latest Stories

Madonna enchanted by Patmos: “I truly felt the presence of God”, see photos

August 21, 2026

Former Abercrombie & Fitch chief executive ruled fit for trial despite Alzheimer’s claims

August 21, 2026

Passengers save bus carrying 50 people in Sweden after driver loses consciousness (video)

August 21, 2026

Global trend for online fame puts lives at risk across Greece

August 21, 2026

Israeli PM Netanyahu brands Turkish President Erdogan ‘antisemitic dictator’ after Interpol arrest warrant

August 21, 2026

Fire on Lemnos prompts evacuation of two villages as 59 residents rescued by sea

August 21, 2026

Prince Harry, Elton John and others ordered to pay Daily Mail £9.5 million by August 28 after losing privacy battle

August 21, 2026

Turkey seeks Interpol “red notice” for Israeli Prime Minister Netanyahu over Gaza flotilla interception

August 21, 2026
All News

> Greece

In reverence, the emotional deposition in Jerusalem, see photos & video

The Holy Temple of the Resurrection opened after many days due to the war between Israel and Iran

April 10, 2026

In the final stretch for the accreditation of joint master’s degrees: Aiming for their launch in the coming academic year

April 10, 2026

Schedule for Epitaph Procession today (10/4)

April 10, 2026

Perfect weather for Easter excursions, according to Tsatrafyllia’s forecast

April 10, 2026

Easter in Greece: The customs that continue in Greek tradition – From Nafpaktos to Corfu

April 10, 2026
Homepage
PERSONAL DATA PROTECTION POLICY COOKIES POLICY TERM OF USE
Powered by Cloudevo
Copyright © 2026 Πρώτο Θέμα